Catalyst Wire Dossier Catalyst Wire Dossier

Tarpeyo

budesonide · Calliditas Therapeutics AB
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Tarpeyo, covering 2021-12-15 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy [Phase 4]

See pricing